We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

FDA Approves Ketamine-derived Nasal Spray for Depression

News   Mar 06, 2019 | Original Press Release from the FDA

 
FDA Approves Ketamine-derived Nasal Spray for Depression

Credit: Pixabay

 
 
Advertisement
 

RELATED ARTICLES

Understanding Autoimmune Psychosis

News

A new study by the University of Barcelona (UB) and the August Pi i Sunyer Biomedical Research Institute (IDIBAPS) shows autoimmune brain illness would be caused by alterations in the quantity of dopaminergic receptors D1R and D2R in the hippocampal area of the brain.

READ MORE

Nanobiologic Approach Trains the Innate Immune System To Eliminate Tumor Cells

News

A novel type of cancer immunotherapy trains the innate immune system to help it eliminate cancer cells through the use of nanobiologics, tiny materials bioengineered from natural molecules that are partnered with a therapeutic component.

READ MORE

New Testing Approach Could Help Scientists Spot Resistance to Cancer Drugs

News

Purdue University engineers have designed a new way to observe pancreatic cancer behavior over time, suggesting a new drug testing approach that could help scientists better catch resistance.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery Neuroscience

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE